Effect of ALDH1A1 and CD44 on Survival and Disease Recurrence in Patients With Osteosarcoma
Authors:
Open Access
- 16 January 2024
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 16 (1) , e52404
Abstract
Purpose: Emerging evidence suggests that osteosarcoma stem cells (OSCs) may be responsible for tumor initiation propagation, recurrence, and resistance to therapy. We set out to evaluate the relationship between the abundance of ALDH1A1 and CD44-positive cells in biopsy and resection samples on disease recurrence and overall survival. Methods: A retrospective review of 20 patients, including biopsy and resection samples, was performed at a comprehensive cancer center. Additionally, we queried the publicly available TARGET dataset of osteosarcoma patients. Results: Neither the percentages of ALDH1A1-positive cells nor CD44-positive cells were significantly associated with overall mortality or disease recurrence in either biopsy or resection samples. Unlike our institutional data, overall survival was significantly correlated to higher ALDH1A1 expression in the TARGET dataset both in univariate and age-adjusted analyses. Conclusions: ADLH1 and CD44, potential markers of OSCs, were not found to be reliable clinical immunohistochemical prognostic markers for osteosarcoma patient survival, specifically disease-free survival. Osteosarcoma patients with high ALDH1A1 RNA expression showed improved overall survival in examining a national genomic database of osteosarcoma patients but again no association with disease-free survival. The potential of CD44 and ALDH1A1 as cellular-specific prognostic markers of survival, and as possible molecular targets, may be limited in osteosarcoma.Keywords
This publication has 29 references indexed in Scilit:
- Aldehyde dehydrogenase 1: A specific cancer stem cell marker for human colorectal carcinomaMolecular Medicine Reports, 2015
- The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: A meta-analysisOral Oncology, 2014
- Prognostic role of CD44 expression in osteosarcoma: evidence from six studiesDiagnostic Pathology, 2014
- ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotypeMedical Oncology, 2014
- Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistanceOncology Reports, 2010
- ALDH1 expression correlates with favorable prognosis in ovarian cancersLaboratory Investigation, 2009
- Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung CancerMolecular Cancer Research, 2009
- Osteosarcoma incidence and survival rates from 1973 to 2004Cancer, 2009
- Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on PrognosisJournal of Clinical Oncology, 2003
- Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma IntergroupEuropean Journal of Cancer, 2002